STAT+: Pharmalittle: We’re reading about an FDA plan for ultra-rare drugs, Novo cutting GLP-1 drug prices, and more
STAT [Unofficial]
February 24, 2026
The Trump administration released detailed guidance for approving the first bespoke medicines crafted to treat individual patient mutations
Discussion in the ATmosphere